title: Why have UK doctors been deterred from prescribing Avastin?
authors.forename: Deborah
authors.initials: D
authors.lastname: Cohen
mesh_terms: D020533:Angiogenesis Inhibitors / Q000191:economics / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000191:economics / Q000627:therapeutic use*; D000068258:Bevacizumab; D004335:Drug and Narcotic Control; D006801:Humans; D056687:Off-Label Use / Q000191:economics / Q000941:ethics / Q000331:legislation & jurisprudence; D010818:Practice Patterns, Physicians' / Q000191:economics / Q000941:ethics / Q000331:legislation & jurisprudence; D013222:State Medicine / Q000191:economics / Q000941:ethics / Q000331:legislation & jurisprudence; D006113:United Kingdom; D057135:Wet Macular Degeneration / Q000188:drug therapy* / Q000191:economics
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab